Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Staten Island, NY
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Staten Island, NY
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Dayton, OH
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Dayton, OH
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Oklahoma City, OK
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Scranton, PA
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Scranton, PA
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Study Site
mi
from
Charleston, SC
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Study Site
mi
from
Charleston, SC
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Study Site
mi
from
Charleston, SC
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Study Site
mi
from
Charleston, SC
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Study Site
mi
from
Charleston, SC
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Study Site
mi
from
Charleston, SC
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Study Site
mi
from
Austin, TX
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Study Site
mi
from
Austin, TX
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Dallas, TX
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Desoto, TX
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Desoto, TX
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Bellevue, WA
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Bellevue, WA
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Burgas,
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Burgas,
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Fort Lauderdale, FL
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated:  2/28/2018
Alkermes Investigational Site
mi
from
Saint Louis, MO
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status: Enrolling
Updated: 2/28/2018
Alkermes Investigational Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Family Based Contingency Management for Adolescent Alcohol Abuse
Family Based Contingency Management for Adolescent Alcohol Abuse
Status: Enrolling
Updated:  3/1/2018
Geisel School of Medicine at Dartmouth
mi
from
Lebanon, NH
Family Based Contingency Management for Adolescent Alcohol Abuse
Family Based Contingency Management for Adolescent Alcohol Abuse
Status: Enrolling
Updated: 3/1/2018
Geisel School of Medicine at Dartmouth
mi
from
Lebanon, NH
Click here to add this to my saved trials
Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
CTN 0064: Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
Status: Enrolling
Updated:  3/1/2018
University Hospital, University of Alabama at Birmingham
mi
from
Birmingham, AL
Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
CTN 0064: Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
Status: Enrolling
Updated: 3/1/2018
University Hospital, University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
CTN 0064: Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
Status: Enrolling
Updated:  3/1/2018
Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center
mi
from
Torrance, CA
Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
CTN 0064: Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
Status: Enrolling
Updated: 3/1/2018
Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center
mi
from
Torrance, CA
Click here to add this to my saved trials
Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
CTN 0064: Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
Status: Enrolling
Updated:  3/1/2018
Jackson Health System Adult HIV Outpatient Clinics / University of Miami
mi
from
Miami, FL
Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
CTN 0064: Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
Status: Enrolling
Updated: 3/1/2018
Jackson Health System Adult HIV Outpatient Clinics / University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
CTN 0064: Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
Status: Enrolling
Updated:  3/1/2018
Grady Memorial Hospital / Ponce de Leon Center
mi
from
Atlanta, GA
Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
CTN 0064: Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
Status: Enrolling
Updated: 3/1/2018
Grady Memorial Hospital / Ponce de Leon Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
CTN 0064: Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
Status: Enrolling
Updated:  3/1/2018
John H. Stroger, Jr. Hospital of Cook County
mi
from
Chicago, IL
Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
CTN 0064: Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
Status: Enrolling
Updated: 3/1/2018
John H. Stroger, Jr. Hospital of Cook County
mi
from
Chicago, IL
Click here to add this to my saved trials
Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
CTN 0064: Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
Status: Enrolling
Updated:  3/1/2018
Johns Hopkins Hospital / Moore Clinic
mi
from
Baltimore, MD
Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
CTN 0064: Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
Status: Enrolling
Updated: 3/1/2018
Johns Hopkins Hospital / Moore Clinic
mi
from
Baltimore, MD
Click here to add this to my saved trials
Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
CTN 0064: Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
Status: Enrolling
Updated:  3/1/2018
Boston University Medical Center
mi
from
Boston, MA
Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
CTN 0064: Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
Status: Enrolling
Updated: 3/1/2018
Boston University Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
CTN 0064: Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
Status: Enrolling
Updated:  3/1/2018
Mount Sinai-St. Luke's Roosevelt Hospital Center
mi
from
New York, NY
Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
CTN 0064: Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
Status: Enrolling
Updated: 3/1/2018
Mount Sinai-St. Luke's Roosevelt Hospital Center
mi
from
New York, NY
Click here to add this to my saved trials
Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
CTN 0064: Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
Status: Enrolling
Updated:  3/1/2018
Hahnemann University Hospital
mi
from
Philadelphia, PA
Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
CTN 0064: Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
Status: Enrolling
Updated: 3/1/2018
Hahnemann University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
CTN 0064: Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
Status: Enrolling
Updated:  3/1/2018
University of Pittsburgh Medical Center Presbyterian / Pittsburgh AIDS Center for Treatment
mi
from
Pittsburgh, PA
Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
CTN 0064: Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
Status: Enrolling
Updated: 3/1/2018
University of Pittsburgh Medical Center Presbyterian / Pittsburgh AIDS Center for Treatment
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
CTN 0064: Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
Status: Enrolling
Updated:  3/1/2018
University of Texas Southwestern
mi
from
Dallas, TX
Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
CTN 0064: Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
Status: Enrolling
Updated: 3/1/2018
University of Texas Southwestern
mi
from
Dallas, TX
Click here to add this to my saved trials
Disseminating Organizational SBI Services at Trauma Centers
Disseminating Organizational SBI Services (DO-SBIS) at Trauma Centers
Status: Enrolling
Updated:  3/2/2018
Univ of Washington
mi
from
Seattle, WA
Disseminating Organizational SBI Services at Trauma Centers
Disseminating Organizational SBI Services (DO-SBIS) at Trauma Centers
Status: Enrolling
Updated: 3/2/2018
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Mindful Hearts Study
Mindfulness Based Stress Reduction for Women at Risk for Cardiovascular Disease
Status: Enrolling
Updated:  3/2/2018
Edward Hines Jr. VA Hospital, Hines, IL
mi
from
Hines, IL
Mindful Hearts Study
Mindfulness Based Stress Reduction for Women at Risk for Cardiovascular Disease
Status: Enrolling
Updated: 3/2/2018
Edward Hines Jr. VA Hospital, Hines, IL
mi
from
Hines, IL
Click here to add this to my saved trials
Couples Therapy to Enhance Intimacy Between Patients With Advanced or Recurrent Prostate Cancer and Their Partners
A Pilot Study of an Intimacy-Enhancing Couples Therapy for Men With Advanced Prostate Cancer and Their Partners
Status: Enrolling
Updated:  3/5/2018
Fox Chase Cancer Center - Cheltenham
mi
from
Philadelphia, PA
Couples Therapy to Enhance Intimacy Between Patients With Advanced or Recurrent Prostate Cancer and Their Partners
A Pilot Study of an Intimacy-Enhancing Couples Therapy for Men With Advanced Prostate Cancer and Their Partners
Status: Enrolling
Updated: 3/5/2018
Fox Chase Cancer Center - Cheltenham
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Couples Therapy to Enhance Intimacy Between Patients With Advanced or Recurrent Prostate Cancer and Their Partners
A Pilot Study of an Intimacy-Enhancing Couples Therapy for Men With Advanced Prostate Cancer and Their Partners
Status: Enrolling
Updated:  3/5/2018
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Couples Therapy to Enhance Intimacy Between Patients With Advanced or Recurrent Prostate Cancer and Their Partners
A Pilot Study of an Intimacy-Enhancing Couples Therapy for Men With Advanced Prostate Cancer and Their Partners
Status: Enrolling
Updated: 3/5/2018
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Effectiveness and Duration of Effect of Open Treatment in Attention Deficit Hyperactivity Disorder (ADHD) Patients Treated With Lisdexamfetamine Dimesylate(Vyvanse)
Evaluation of Pharmacokinetics and Profile of Clinical Response of Subacute Lisdexamfetamine Dimesylate (Vyvanse) Treatment vs. Clinical Response to Subacute Immediate Release Mixed Amphetamine Salt Therapy in Adult ADHD
Status: Enrolling
Updated:  3/5/2018
NYU School of Medicine
mi
from
New York, NY
Effectiveness and Duration of Effect of Open Treatment in Attention Deficit Hyperactivity Disorder (ADHD) Patients Treated With Lisdexamfetamine Dimesylate(Vyvanse)
Evaluation of Pharmacokinetics and Profile of Clinical Response of Subacute Lisdexamfetamine Dimesylate (Vyvanse) Treatment vs. Clinical Response to Subacute Immediate Release Mixed Amphetamine Salt Therapy in Adult ADHD
Status: Enrolling
Updated: 3/5/2018
NYU School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
The SOMNUS Study: Sedative Optimization Via Monitoring Neurological Status
A Randomized Control Trial Using the BIS Monitor to Avoid Over Sedation and Prolonged Neuropsychological Deficits in Mechanically Ventilated ICU Patients
Status: Enrolling
Updated:  3/6/2018
Vanderbilt University Medical Center
mi
from
Nashville, TN
The SOMNUS Study: Sedative Optimization Via Monitoring Neurological Status
A Randomized Control Trial Using the BIS Monitor to Avoid Over Sedation and Prolonged Neuropsychological Deficits in Mechanically Ventilated ICU Patients
Status: Enrolling
Updated: 3/6/2018
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Now Matters Now: An Online Suicide Prevention Program
Pilot Study of Online Interventions for Population-based Suicide
Status: Enrolling
Updated:  3/6/2018
Group Health Research Institute
mi
from
Seattle, WA
Now Matters Now: An Online Suicide Prevention Program
Pilot Study of Online Interventions for Population-based Suicide
Status: Enrolling
Updated: 3/6/2018
Group Health Research Institute
mi
from
Seattle, WA
Click here to add this to my saved trials
Mobile Health Application for Family and Behavioral Health Provider Communication
Mobile Health Application for Family and Behavioral Health Provider Communication
Status: Enrolling
Updated:  3/6/2018
Duke University, Department of Psychiatry
mi
from
Durham, NC
Mobile Health Application for Family and Behavioral Health Provider Communication
Mobile Health Application for Family and Behavioral Health Provider Communication
Status: Enrolling
Updated: 3/6/2018
Duke University, Department of Psychiatry
mi
from
Durham, NC
Click here to add this to my saved trials
Uridine Adolescent Bipolar Depression Randomized Controlled Trial
Placebo-Controlled Study of Uridine for Adolescent Bipolar Depression: a Magnetic Resonance Spectroscopy Study
Status: Enrolling
Updated:  3/7/2018
University of Utah
mi
from
Salt Lake City, UT
Uridine Adolescent Bipolar Depression Randomized Controlled Trial
Placebo-Controlled Study of Uridine for Adolescent Bipolar Depression: a Magnetic Resonance Spectroscopy Study
Status: Enrolling
Updated: 3/7/2018
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
The Effect of N-Acetyl Cysteine on Cortical Erosion in Early Stage Schizophrenia
Status: Enrolling
Updated:  3/8/2018
Prevention and Recovery Center for Early Psychosis (PARC)
mi
from
Indianapolis, IN
The Effect of N-Acetyl Cysteine on Cortical Erosion in Early Stage Schizophrenia
Status: Enrolling
Updated: 3/8/2018
Prevention and Recovery Center for Early Psychosis (PARC)
mi
from
Indianapolis, IN
Click here to add this to my saved trials
The Effect of N-Acetyl Cysteine on Cortical Erosion in Early Stage Schizophrenia
Status: Enrolling
Updated:  3/8/2018
Indiana University Psychotic Disorders Clinic
mi
from
Indianapolis, IN
The Effect of N-Acetyl Cysteine on Cortical Erosion in Early Stage Schizophrenia
Status: Enrolling
Updated: 3/8/2018
Indiana University Psychotic Disorders Clinic
mi
from
Indianapolis, IN
Click here to add this to my saved trials
ASD Parent Trainer: Online Coaching for Parents of Children With Autism
Status: Enrolling
Updated:  3/8/2018
IRIS Educational Media
mi
from
Eugene, OR
ASD Parent Trainer: Online Coaching for Parents of Children With Autism
Status: Enrolling
Updated: 3/8/2018
IRIS Educational Media
mi
from
Eugene, OR
Click here to add this to my saved trials
Audiovisual Aid Pilot Study
The Effect of Audiovisual Aids on Perioperative Stress Response, Pain and Overall Experience - a Randomized Controlled Pilot Study
Status: Enrolling
Updated:  3/8/2018
Hospital for Special Surgery (HSS)
mi
from
New York, NY
Audiovisual Aid Pilot Study
The Effect of Audiovisual Aids on Perioperative Stress Response, Pain and Overall Experience - a Randomized Controlled Pilot Study
Status: Enrolling
Updated: 3/8/2018
Hospital for Special Surgery (HSS)
mi
from
New York, NY
Click here to add this to my saved trials
Mirtazapine for the Treatment of Methamphetamine Dependence Among MSM (M2.0)
Mirtazapine for the Treatment of Methamphetamine Dependence Among MSM: a 6-month Randomized Controlled Trial With 3 Months of Follow-up
Status: Enrolling
Updated:  3/9/2018
Substance Use Research Unit
mi
from
San Francisco, CA
Mirtazapine for the Treatment of Methamphetamine Dependence Among MSM (M2.0)
Mirtazapine for the Treatment of Methamphetamine Dependence Among MSM: a 6-month Randomized Controlled Trial With 3 Months of Follow-up
Status: Enrolling
Updated: 3/9/2018
Substance Use Research Unit
mi
from
San Francisco, CA
Click here to add this to my saved trials
Culturally Grounded Early Substance Use Prevention for American Indian Families
Culturally Grounded Early Substance Use Prevention for American Indian Families
Status: Enrolling
Updated:  3/9/2018
Clinical Research Facility
mi
from
Denver, CO
Culturally Grounded Early Substance Use Prevention for American Indian Families
Culturally Grounded Early Substance Use Prevention for American Indian Families
Status: Enrolling
Updated: 3/9/2018
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Transcranial Direct Current Stimulation for Hallucinations in First-Episode Schizophrenia
Transcranial Direct Current Stimulation for Hallucinations in First-Episode Schizophrenia
Status: Enrolling
Updated:  3/9/2018
The Zucker Hillside Hospital
mi
from
Glen Oaks, NY
Transcranial Direct Current Stimulation for Hallucinations in First-Episode Schizophrenia
Transcranial Direct Current Stimulation for Hallucinations in First-Episode Schizophrenia
Status: Enrolling
Updated: 3/9/2018
The Zucker Hillside Hospital
mi
from
Glen Oaks, NY
Click here to add this to my saved trials
Cannabis and Schizophrenia: Self-Medication and Agonist Treatment
Cannabis and Schizophrenia: Self-Medication and Agonist Treatment
Status: Enrolling
Updated:  3/12/2018
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Cannabis and Schizophrenia: Self-Medication and Agonist Treatment
Cannabis and Schizophrenia: Self-Medication and Agonist Treatment
Status: Enrolling
Updated: 3/12/2018
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
A Study of Quetiapine and Mirtazapine for the Treatment of Alcohol Dependency
An Open-Label, Sequential Study of Quetiapine Fumarate Extended Release (XR) and Mirtazapine for the Treatment of Alcohol Dependency in Very Heavy Drinkers
Status: Enrolling
Updated:  3/12/2018
Dartmouth Medical School Department of Psychiatry's Addition Research Center
mi
from
Bedford, NH
A Study of Quetiapine and Mirtazapine for the Treatment of Alcohol Dependency
An Open-Label, Sequential Study of Quetiapine Fumarate Extended Release (XR) and Mirtazapine for the Treatment of Alcohol Dependency in Very Heavy Drinkers
Status: Enrolling
Updated: 3/12/2018
Dartmouth Medical School Department of Psychiatry's Addition Research Center
mi
from
Bedford, NH
Click here to add this to my saved trials
A Study of Quetiapine and Mirtazapine for the Treatment of Alcohol Dependency
An Open-Label, Sequential Study of Quetiapine Fumarate Extended Release (XR) and Mirtazapine for the Treatment of Alcohol Dependency in Very Heavy Drinkers
Status: Enrolling
Updated:  3/12/2018
Dartmouth Medical School Department of Psychiatry's Addiction Research Center
mi
from
Hanover, NH
A Study of Quetiapine and Mirtazapine for the Treatment of Alcohol Dependency
An Open-Label, Sequential Study of Quetiapine Fumarate Extended Release (XR) and Mirtazapine for the Treatment of Alcohol Dependency in Very Heavy Drinkers
Status: Enrolling
Updated: 3/12/2018
Dartmouth Medical School Department of Psychiatry's Addiction Research Center
mi
from
Hanover, NH
Click here to add this to my saved trials
Valproic Acid for Treatment of Hyperactive or Mixed Delirium in ICU
Valproic Acid for Treatment of Hyperactive or Mixed Delirium in ICU
Status: Enrolling
Updated:  3/12/2018
Stanford Hospital and Clinics
mi
from
Stanford, CA
Valproic Acid for Treatment of Hyperactive or Mixed Delirium in ICU
Valproic Acid for Treatment of Hyperactive or Mixed Delirium in ICU
Status: Enrolling
Updated: 3/12/2018
Stanford Hospital and Clinics
mi
from
Stanford, CA
Click here to add this to my saved trials
Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder
Efficacy of Quetiapine in Treating Patients With Active Substance Use Disorder and Schizophrenia
Status: Enrolling
Updated:  3/12/2018
Medical College of Georgia
mi
from
Augusta, GA
Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder
Efficacy of Quetiapine in Treating Patients With Active Substance Use Disorder and Schizophrenia
Status: Enrolling
Updated: 3/12/2018
Medical College of Georgia
mi
from
Augusta, GA
Click here to add this to my saved trials
Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder
Efficacy of Quetiapine in Treating Patients With Active Substance Use Disorder and Schizophrenia
Status: Enrolling
Updated:  3/12/2018
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder
Efficacy of Quetiapine in Treating Patients With Active Substance Use Disorder and Schizophrenia
Status: Enrolling
Updated: 3/12/2018
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder
Efficacy of Quetiapine in Treating Patients With Active Substance Use Disorder and Schizophrenia
Status: Enrolling
Updated:  3/12/2018
West Central Behavioral Health
mi
from
Lebanon, NH
Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder
Efficacy of Quetiapine in Treating Patients With Active Substance Use Disorder and Schizophrenia
Status: Enrolling
Updated: 3/12/2018
West Central Behavioral Health
mi
from
Lebanon, NH
Click here to add this to my saved trials
Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder
Efficacy of Quetiapine in Treating Patients With Active Substance Use Disorder and Schizophrenia
Status: Enrolling
Updated:  3/12/2018
Mental Health Center of Greater Manchester
mi
from
Manchester, NH
Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder
Efficacy of Quetiapine in Treating Patients With Active Substance Use Disorder and Schizophrenia
Status: Enrolling
Updated: 3/12/2018
Mental Health Center of Greater Manchester
mi
from
Manchester, NH
Click here to add this to my saved trials